MELISSA NAYLOR: Open Payments
NPI 1801086764 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,411 in 18 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $411 · 2025 $3,411
Travel & lodging: $1,745Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $1,921 |
| Medtronic, Inc. | 2 | $254 |
| Radius Health, Inc. | 2 | $219 |
| Abbott Laboratories | 1 | $176 |
| Dexcom, Inc. | 1 | $153 |
| Insulet Corporation | 1 | $149 |
| Sequel Med Tech, LLC | 1 | $145 |
| BETA BIONICS, INC. | 1 | $121 |
| Lilly USA, LLC | 1 | $115 |
| Novo Nordisk Inc | 1 | $111 |
Products named: MINIMED 780G, Tymlos, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, OMNIPOD, TWIIST, iLet Bionic Pancreas, MOUNJARO.
Industry payments across CA — which companies pay providers there.
